CATAPRES labels and packages: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Clonidine}} {{CMG}}; {{AE}} {{PB}} '''''For patient information, click here'''''. ==Labels And Packages== <ref name="dailyme...") |
|||
| Line 6: | Line 6: | ||
==Labels And Packages== | ==Labels And Packages== | ||
Catapres 0.1 mg | |||
100 tablets | |||
NDC-0597-0006-01 | |||
{| | |||
|- | |||
|[[Image:Clonidine15.PNG|thumb|800px]] | |||
|- | |||
|} | |||
Catapres 0.2 mg | |||
100 tablets | |||
NDC-0597-0007-01 | |||
{| | |||
|- | |||
|[[Image:Clonidine16.PNG|thumb|800px]] | |||
|- | |||
|} | |||
Catapres 0.3 mg | |||
100 tablets | |||
NDC-0597-0011-01 | |||
{| | |||
|- | |||
|[[Image:Clonidine17.PNG|thumb|800px]] | |||
|- | |||
|} | |||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = CATAPRES (CLONIDINE HYDROCHLORIDE) TABLET [BOEHRINGER INGELHEIM PHARMACEUTICALS INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d7f569dc-6bed-42dc-9bec-940a9e6b090d | publisher = | date = | accessdate = 5 February 2014 }}</ref> | <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = CATAPRES (CLONIDINE HYDROCHLORIDE) TABLET [BOEHRINGER INGELHEIM PHARMACEUTICALS INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d7f569dc-6bed-42dc-9bec-940a9e6b090d | publisher = | date = | accessdate = 5 February 2014 }}</ref> | ||
==References== | ==References== | ||
Revision as of 05:43, 6 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]
For patient information, click here.
Labels And Packages
Catapres 0.1 mg 100 tablets NDC-0597-0006-01
 |
Catapres 0.2 mg
100 tablets
NDC-0597-0007-01
 |
Catapres 0.3 mg 100 tablets NDC-0597-0011-01
 |
References
- ↑ "CATAPRES (CLONIDINE HYDROCHLORIDE) TABLET [BOEHRINGER INGELHEIM PHARMACEUTICALS INC.]". Retrieved 5 February 2014.